iNK Platform Programs
Hematological and Solid Tumors
Pre-clinicalActive
Key Facts
About Shoreline Biosciences
Shoreline Biosciences is a private, pre-clinical stage biotech founded in 2020 and headquartered in San Diego, CA. The company is pioneering a platform for developing homogeneous, scalable, 'off-the-shelf' cellular immunotherapies using engineered iPSC-derived natural killer cells and macrophages. Its approach aims to overcome key limitations of autologous cell therapies, such as manufacturing complexity, high cost, and product variability. Shoreline is building a pipeline of candidates targeting cancer and other serious diseases, positioning itself in the competitive but high-potential allogeneic cell therapy space.
View full company profileTherapeutic Areas
Other Hematological and Solid Tumors Drugs
| Drug | Company | Phase |
|---|---|---|
| CAR-T Program(s) | Celluris | Pre-clinical / Early Clinical |
| Not Disclosed | ONK Therapeutics | Preclinical |
| CAR-iNKT Programs | MiNK Therapeutics | Preclinical |